Table 3.
Overall Incidence Rates of First-Time Infections for Categories with Four or More First Events Among Patients Enrolled in NISDI Compared with PACTG 219C
|
NISDIa |
PACTG 219C3 |
|
||||
---|---|---|---|---|---|---|---|
Category | Incident events | Person Years | IR of events/100 person years (95% CI) | Incident events | Person Years | IR of events/100 person years (95% CI) | pb |
Overall first infectionsc | 383 | 1633 | 23.45 (21.10–25.80) | — | — | — | |
Bacterial pneumonia | 170 | 2174 | 7.82 (6.64–8.99) | 123 | 5726 | 2.15 (1.79–2.56) | <0.001 |
Varicella | 71 | 2385 | 2.98 (2.28–3.67) | 29 | 6623 | 0.44 (0.29–0.63) | <0.001 |
Dermatophyte infections | 69 | 2409 | 2.86 (2.19–3.54) | 57 | 6483 | 0.88 (0.67–1.14) | <0.001 |
Herpes simplex virus | 60 | 2440 | 2.46 (1.84–3.08) | 11 | 7807 | 0.14 (0.07–0.25) | <0.001 |
Herpes zoster | 45 | 2460 | 1.83 (1.29–2.36) | 77 | 6925 | 1.11 (0.88–1.39) | 0.02 |
Abscess, bacterialc | 37 | 2448 | 1.51 (1.02–2.00) | — | — | — | |
Oral candidiasis | 36 | 2466 | 1.46 (0.98–1.94) | 52 | 5576 | 0.93 (0.70–1.22) | 0.06 |
Molluscum contagiosum | 31 | 2461 | 1.26 (0.82–1.70) | 23 | 7392 | 0.31 (0.20–0.47) | <0.001 |
Lymphadenitis | 22 | 2495 | 0.88 (0.51–1.25) | 7 | 7849 | 0.09 (0.04–0.18) | <0.001 |
Urinary tract infection | 19 | 2509 | 0.76 (0.42–1.10) | 27 | 7660 | 0.35 (0.23–0.51) | 0.03 |
Infectious diarrhea | 18 | 2497 | 0.72 (0.39–1.05) | 9 | 7552 | 0.12 (0.05–0.23) | <0.001 |
P. jiroveci pneumonia | 9 | 2526 | 0.36 (0.12–0.59) | 7 | 7668 | 0.09 (0.04–0.19) | 0.03 |
Lymphoid interstitial pneumonitis | 7 | 2533 | 0.28 (0.07–0.48) | 6 | 6889 | 0.09 (0.03–0.19) | 0.09 |
Bacterial meningitisc | 7 | 2522 | 0.28 (0.07–0.48) | — | — | — | |
Tuberculosis (TB) | 7 | 2523 | 0.28 (0.07–0.48) | <4 | — | — | |
Viral hepatitis | 6 | 2525 | 0.24 (0.05–0.43) | 11 | 7729 | 0.14 (0.07–0.25) | 0.37 |
Bacteremia/septicemia | 5 | 2529 | 0.20 (0.02–0.37) | 25 | 7192 | 0.35 (0.22–0.51) | 0.18 |
CMV not retinitisc | 4 | 2534 | 0.16 (0.0–0.31) | — | — | — |
NISDI reported <4 events for toxoplasmosis (3), non-TB mycobacteria (2), esophageal or pulmonary candidiasis (2), Cryptosporidium (2)c, progressive multifocal leukoencephalopathy (2)c, CMV retinitis (1), encephalitis (1)c, septic arthritis, bacterial (1)c.
Fisher's exact test.
Not reported in PACTG 219C.3
IR, incidence rate; CMV, cytomegalovirus.